Cite Filings / ALZN / 0001214659-21-009448
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Alzamend Neuro, Inc. · Filed 2021-09-13 · Acc 0001214659-21-009448

Documents 1

  • 10-Q Quarterly Report , p9821110q.htm

Around this filing

  • 2021-12-13 10-Q Quarterly Report
  • 2021-09-15 4 Director acquired 2,778 shares (option exercise)
  • 2021-09-15 4 Director acquired 2,778 shares (option exercise)
  • 2021-09-15 4 Director acquired 2,778 shares (option exercise)
  • 2021-09-15 4 Director acquired 2,778 shares (option exercise)
  • 2021-09-13 10-Q Quarterly Report
  • 2021-09-10 4 Director acquired 100,000 shares (option exercise)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading p9821110q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…